Is Quest Diagnostics Stock a Hidden Gem for Investors?
In this episode of Motley Fool Scoreboard, Anand Chokkavelu, along with Karl Thiel and Keith Speights, dive deep into Quest Diagnostics (DGX). They evaluate its business strength, management effectiveness, financial health, and future growth potential. Discover why they rated Quest a solid 6.8 out of 10 and what it means for investors.
————————————————————————
This video is brought to you by The Motley Fool.
Visit https://fool.com/Invest to get access to this special offer. The Motley Fool Stock Advisor returns are 860% as of 8/19/2025 and measured against the S&P 500 returns of 185% as of 8/19/2025. Past performance is not an indicator of future results. All investing involves a risk of loss. Individual investment results may vary, not all Motley Fool Stock Advisor picks have performed as well.
